Seizure Disorders

Latest News

Unapproved Cannabidiol, Curcumin Injectables Marketed for Multiple Disorders Recalled

Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.

Epilepsy and COVID-19: Connection and Considerations

A brief communication provides information about the associations between, and the considerations for, COVID-19 and epilepsy.

STOPBAG2 Offers High Discriminatory Power for Predicting OSA Severity in Adults With Epilepsy

The STOPBAG2 scoring instrument, which incorporates sleep-related symptoms and continuous variables for age and BMI, offers greater discriminatory power for predicting all levels of OSA severity in adults with epilepsy.

Cannabidiol Is Safe and Effective for Patients With Lennox Gastaut Syndrome

Add-on cannabidiol was found to be safe and effective for patients with Lennox Gastaut Syndrome.

Risk for Cardiovascular Disease Found to Be Higher in Status Epilepticus

Individuals with vs without status epilepticus were found to have a greater prevalence of cardiovascular risk factors and a higher risk of developing cardiovascular diseases.

DEA Deschedules Prescription CBD Drug Epidiolex

Epidiolex® (cannabidiol; GW Pharmaceuticals) oral solution is no longer a controlled substance, according to the Drug Enforcement Administration.

Epidiolex Gets Priority Review for Tuberous Sclerosis Complex-Associated Seizures

The FDA has accepted for Priority Review the supplemental New Drug Application for Epidiolex.

Cannabidiol as an Adjunctive Therapy for Patients With Treatment-Resistant Dravet Syndrome

Investigators assessed the efficacy and safety of 2 daily doses of cannabidiol, 10 mg/kg or 20 mg/kg, in children with Dravet syndrome.

Epilepsy Therapy Cenobamate Designated Schedule V Controlled Substance

The DEA has designated Xcopri (cenobamate; SK Life Science) as a schedule V controlled substance, indicating a lower potential for abuse.

FDA Approves MRI Labeling for Neurostimulation System Designed to Prevent Seizures

The RNS System consists of a small neurostimulator that is surgically implanted into the skull, delivering an electrical stimulation to the brain via leads when abnormal activity is detected.